Intrinsic Value of S&P & Nasdaq Contact Us

Cingulate Inc. CINGW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
32/100
1/5 Pass
SharesGrow Intrinsic Value
$2,260,930.00
+10766333233.3%

Cingulate Inc. (CINGW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysts estimate Earnings Per Share (EPS) of $-9.44 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-8.80 vs est $-9.44 (beat +6.7%). 2025: actual $-4.13 vs est $-3.82 (missed -8.1%). Analyst accuracy: 93%.

EPS Estimates — CINGW

93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$8.80 vs Est –$9.44 ▲ 7.2% off
2025 Actual –$4.13 vs Est –$3.82 ▼ 7.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — CINGW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message